SF3B1’s mutational frequency is particularly striking in MDS patients and in a particular subset where bone marrow evaluation identifies iron-laden mitochondrial deposits (ringed sideroblasts). This evidence concerns the gene SF3B1 and myelodysplastic syndrome.